"10.1371_journal.pone.0129465","plos one","2015-06-09T00:00:00Z","Ashley T Haase; Eva Rakasz; Nancy Schultz-Darken; Karla Nephew; Kimberly L Weisgrau; Cavan S Reilly; Qingsheng Li; Peter J Southern; Meghan Rothenberger; Marnie L Peterson; Patrick M Schlievert","Department of Microbiology and Immunobiology, Medical School, University of Minnesota, Minneapolis, MN 55455, United States of America; Wisconsin National Primate Research Center, University of Wisconsin, Madison, WI 53715, United States of America; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN 55455, United States of America; Division of Infectious Diseases, Department of Medicine, Medical School, University of Minnesota, Minneapolis, MN 55455, United States of America; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, United States of America","Conceived and designed the experiments: ATH. Performed the experiments: ER NSD KN KW. Analyzed the data: ATH ER NSD CSR PJS MR PMS. Contributed reagents/materials/analysis tools: ER NSD MR MLP PMS. Wrote the paper: ATH ER NSD KN KW CSR QL PJS MR MLP PMS.","PMS is co-founder of a small business, Hennepin Life Sciences, which has licensed a patent awarded to the University of Minnesota for the development of glycerol monolaurate (GML) to treat vaginal bacterial infections. PMS receives no salary or consulting support from Hennepin Life Sciences, though he does have stock in the company. PMS and MLP are co-inventors on the above GML patent awarded to the University of Minnesota. The title of this patent is: Compositions and Methods for Controlling Infections (US 8796332 B2). The authors confirm that the patent and stock do not alter adherence to all PLOS ONE policies on sharing data and materials.","2015","06","Ashley T Haase","ATH",11,TRUE,1,4,7,11,TRUE,TRUE,FALSE,0,NA,FALSE
